On January 24, 2024, Establishment Labs Holdings Inc. closed the transaction. The company has now issued 1,101,565 common shares at a price of $25 per share for the gross proceeds of $27,539,125 and 898,435 warrants at a price of $24.999 per warrant for the gross proceeds of $22,459,976.565; for total gross proceeds of $49,999,101.565 pursuant to Regulation D. The transaction included participation from 10 investors.
Establishment Labs Holdings Inc.
Equities
ESTA
VGG312491084
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.02 USD | -1.15% |
|
+2.95% | +69.91% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+69.91% | 1.23B | |
-4.56% | 184B | |
-2.73% | 103B | |
-4.88% | 67.59B | |
+15.69% | 46.93B | |
-8.56% | 43.87B | |
+8.28% | 41.2B | |
+17.13% | 30.47B | |
+13.59% | 24.16B | |
-7.54% | 23.57B |
- Stock Market
- Equities
- ESTA Stock
- News Establishment Labs Holdings Inc.
- Establishment Labs Holdings Inc. announced that it has received $49.999102 million in funding